26 min listen
EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics
EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics
ratings:
Length:
43 minutes
Released:
Jun 29, 2022
Format:
Podcast episode
Description
This week Patrick is joined by Dietrich Stephan, Founder and CEO of NeuBase Therapeutics. They discuss how to overcome the challenges of ’un-druggable’ diseases, how Neubase is cracking the druggable genome using its scalable technology, and how biotech companies are innovating to secure the investment needed to accelerate precision medicine during a challenging period for the industry.
Released:
Jun 29, 2022
Format:
Podcast episode
Titles in the series (100)
EP 6 The Phlebotomist Depicts a Dystopian Future Governed by DNA Testing: The Phlebotomist is a play written by Ella Road which imagines a future where your genetic rating influences every aspect of your life and is determined through a single blood test. We spoke with Ella to find out about her inspiration and the cross... by The Genetics Podcast